Katayoun Rezvani
MD, PhD, FRCP
Professor; Chief, Cellular Therapy Section
👥Biography 个人简介
Katayoun Rezvani is a world leader in developing iPSC-derived and cord blood-derived NK cell therapies for hematologic malignancies. She led the landmark clinical study of cord blood-derived CAR-NK cells targeting CD19 in lymphoid malignancies, demonstrating remarkable clinical responses with minimal toxicity compared to CAR-T cells. Her laboratory focuses on scalable manufacturing of NK cell products from iPSCs and cord blood. She has pioneered genetic engineering strategies to enhance NK cell persistence, cytotoxicity, and homing to tumor sites.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Katayoun Rezvani 的研究动态
Follow Katayoun Rezvani's research updates
留下邮箱，当我们发布与 Katayoun Rezvani（University of Texas MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment